Anthony Petrone
Stock Analyst at Mizuho
(3.92)
# 634
Out of 5,051 analysts
196
Total ratings
52.14%
Success rate
9.49%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Outperform | $310 → $300 | $245.22 | +22.34% | 18 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 → $100 | $82.84 | +20.71% | 10 | Oct 31, 2025 | |
| HOLX Hologic | Downgrades: Neutral | $70 → $78 | $74.23 | +5.08% | 10 | Oct 23, 2025 | |
| GH Guardant Health | Maintains: Outperform | $65 → $70 | $95.05 | -26.35% | 3 | Sep 25, 2025 | |
| ALC Alcon | Maintains: Outperform | $120 → $110 | $74.34 | +47.97% | 10 | Aug 21, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $50.72 | +38.01% | 15 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $120 → $70 | $57.23 | +22.31% | 6 | Aug 7, 2025 | |
| TFX Teleflex | Maintains: Neutral | $130 → $135 | $124.75 | +8.22% | 9 | Aug 1, 2025 | |
| ABT Abbott Laboratories | Maintains: Neutral | $140 → $135 | $124.54 | +8.40% | 6 | Jul 18, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $105 → $90 | $68.88 | +30.66% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $25.25 | -28.71% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $100 | $90.40 | +10.62% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $70 | $60.51 | +15.68% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $13.86 | -13.42% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $59.28 | +68.69% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $84.35 | +107.47% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $6.73 | +494.35% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $14.67 | +36.33% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $69.63 | -13.83% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $68.20 | -14.96% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $60 | $50.81 | +18.09% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $98.90 | +11.22% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $15.37 | -8.91% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $75.61 | +38.87% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $82.82 | +201.86% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $7.96 | +75.88% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $548.55 | -28.90% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $86.26 | -22.33% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $87.55 | +99.89% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $11.86 | +110.79% | 3 | May 13, 2020 |
ResMed
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $245.22
Upside: +22.34%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $90 → $100
Current: $82.84
Upside: +20.71%
Hologic
Oct 23, 2025
Downgrades: Neutral
Price Target: $70 → $78
Current: $74.23
Upside: +5.08%
Guardant Health
Sep 25, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $95.05
Upside: -26.35%
Alcon
Aug 21, 2025
Maintains: Outperform
Price Target: $120 → $110
Current: $74.34
Upside: +47.97%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $50.72
Upside: +38.01%
Lantheus Holdings
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $57.23
Upside: +22.31%
Teleflex
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $124.75
Upside: +8.22%
Abbott Laboratories
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $124.54
Upside: +8.40%
The Cooper Companies
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $68.88
Upside: +30.66%
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $25.25
Upside: -28.71%
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $90.40
Upside: +10.62%
Jul 16, 2025
Maintains: Outperform
Price Target: $58 → $70
Current: $60.51
Upside: +15.68%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $13.86
Upside: -13.42%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $59.28
Upside: +68.69%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $84.35
Upside: +107.47%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $6.73
Upside: +494.35%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $14.67
Upside: +36.33%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $69.63
Upside: -13.83%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $68.20
Upside: -14.96%
Feb 26, 2025
Maintains: Outperform
Price Target: $70 → $60
Current: $50.81
Upside: +18.09%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $98.90
Upside: +11.22%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $15.37
Upside: -8.91%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $75.61
Upside: +38.87%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $82.82
Upside: +201.86%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $7.96
Upside: +75.88%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $548.55
Upside: -28.90%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $86.26
Upside: -22.33%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $87.55
Upside: +99.89%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $11.86
Upside: +110.79%